Clinical head-to-head data from the SURPASS trials showed tirzepatide producing greater triglyceride reductions than semaglutide at comparable doses, which aligns with the expectation that GIP activation adds a lipid-specific benefit beyond what GLP-1 alone provides
The postprandial glucose control mediated by the short-acting GLP-1 RA seems to be primarily explained through the delaying effect on gastric emptying rather than the effect on insulin and glucagon secretion
Current evidence suggests minimal infant exposure, but many clinicians recommend waiting until breastfeeding ends or switching to formula if starting GLP-1 treatment
Sanders-Van Wijk S, Van Empel V, Davarzani N et al (2015) Circulating biomarkers of distinct pathophysiological pathways in heart failure with preserved vs
77 Additionally, elevated expression of ZIP13 activates the Src/FAK pathway, leading to increased expression of pro-tumor metastatic genes but decreased expression of tumor suppressor genes in ovarian cancer
The 20mg vial format discussed in this guide reflects the research market, not pharmaceutical packaging that would come with eventual approval
